Colgate-Palmolive Q1 2026 Earnings: Revenue Hits $5.2B, Beats Estimates
Colgate-Palmolive (CL) reported Q1 2026 results with revenue of $5.2 billion, up 4.5% year-over-year, beating analyst estimates of $5.1 billion. EPS was $0.85, slightly up from $0.83 a year ago. The company raised its full-year guidance, citing strong organic growth and margin expansion.
Key Numbers
Colgate-Palmolive (CL) announced its first-quarter 2026 financial results, posting revenue of $5.2 billion, a 4.5% increase compared to $4.98 billion in the same period last year, and surpassing analyst expectations of $5.1 billion. Earnings per share (EPS) came in at $0.85, up from $0.83 in Q1 2025, reflecting modest profit growth.
Key Financial Metrics
| Metric | Q1 2026 | Q1 2025 | Change |
|---|---|---|---|
| Revenue | $5.2B | $4.98B | +4.5% |
| Net Income | $720M | $700M | +2.9% |
| EPS | $0.85 | $0.83 | +2.4% |
Highlights from the Report
The company attributed revenue growth to higher volumes in emerging markets, particularly Latin America and Asia, as well as an improved product mix and selective price increases. Gross margin expanded by 50 basis points to 59.5%, driven by supply chain efficiencies.
Guidance
Colgate-Palmolive raised its full-year 2026 guidance, now expecting organic revenue growth of 3-5% (up from 2-4% previously) and EPS in the range of $3.50 to $3.60. The company also reaffirmed its $1.5 billion share repurchase program.
Stock Impact
CL shares rose 1.2% in pre-market trading following the announcement, reflecting investor optimism. The stock currently trades at $98.50, up 8% year-to-date.
What This Means for Investors
Colgate-Palmolive's results highlight resilient demand for consumer staples, especially in emerging markets. The guidance raise signals management confidence in sustained momentum. However, investors should monitor inflationary pressures on raw material costs and currency fluctuations.
Frequently Asked Questions
Found this useful? Share it